HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $28 Price Target

Benzinga · 10/11 10:11
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MediWound (NASDAQ:MDWD) with a Buy and maintains $28 price target.